Alyeska Investment Group
ECYT

Alyeska Investment Group’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Alyeska Investment Group’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-53,945
Closed -$958K – 531
2018
Q3 		$958K Buy
+53,945
New +$926K 0.01% 351

Other funds holding ECYT

OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
CA
Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Alyeska Investment Group's ECYT Position: Q4 2018 in Review

Alyeska Investment Group sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 53,945 shares — an estimated $958K sold.

Alyeska Investment Group first reported a position in ECYT in Q3 2018 and held it in 1 quarter. The position peaked at $958K in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

  • Alyeska Investment Group reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Alyeska Investment Group sold 53,945 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $958K.
  • Alyeska Investment Group first reported a position in Endocyte, Inc. Common Stock in Q3 2018 and held it in 1 quarter.
  • Alyeska Investment Group's Endocyte, Inc. Common Stock position peaked at $958K in Q3 2018.
  • 2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Alyeska Investment Group's 13F filing for Q4 2018, filed 14 Feb 2019.